Sponsored by the HealthcareTrainingInstitute.org providing Quality Education since 1979
Add to Shopping Cart

HIV: Effective Tools & Techniques for the Caregiver
6 CEUs Cultural Diversity & Ethical Boundaries: Freedom from Stereotypes

Section 18
State HIV Prevention Progress Report 2014

Answer Booklet | Table of Contents | HIV/AIDS CEU Courses
Psychologist CEs, Counselor CEUs, Social Worker CEUs, MFT CEUs


The Flip Book below is from Centers for Disease Control and Prevention 

Hint:
1. Use + and – at top of page to increase or decrease size
2. Click and drag on page to move text to be more visible , if needed
3. Click speaker at top of page to add or delete sound
4. If message below indicates "A plugin is needed to display this content." CLICK HERE
Questions? Email: [email protected]

- Dietz, Patricia M. ,DrPH, Amy L. Krueger, MPH, Richard J. Wolitski, PhD, Anna Satcher Johnson, MPH, Erica Dunbar, MPH, Lillian S. Lin, PhD, Samuel Dooley, MD, Donna Hubbard McCree, PhD, Shubha Rao, MPH, H. Irene Hall, PhD Dale Stratford, PhD, State HIV Prevention Progress Report 2014, Centers for Disease Control and Prevention 2014, p1-108.


 
Others who bought this HIV/AIDS Course
also bought…

Scroll DownScroll UpCourse Listing Bottom Cap

Answer Booklet for this course | HIV/AIDS
Forward to Section 19
Back to Section 17
Table of Contents
Top

The article above contains foundational information. Articles below contain optional updates.
Trans women wary of antiretroviral drug and hormone interactions - August 23, 2017
Transgender women living with HIV may be hesitant to use antiretroviral therapy (ART) or not take it as prescribed because of concerns about drug interactions with feminising hormones, according to a presentation at the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris. "Trans women expressed concerned about potential ART and
Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection - August 22, 2017
Menopause is associated with accelerated liver fibrosis in women with HIV and hepatitis C virus (HCV) co-infection, investigators from the United States report in the online edition of Clinical Infectious Diseases. The study showed that liver damage due to fibrosis – the build-up of scar tissue after cell death caused by HCV-related inflammation –
People with HIV are at risk for liver fibrosis and steatosis - August 21, 2017
Metabolic syndrome, type 2 diabetes and obesity are risk factors for the development of liver fibrosis and steatosis (liver fat accumulation) in people living with HIV, including those who do not have viral hepatitis co-infection, according to research presented at the 9th International AIDS Society Conference on HIV Science (IAS
Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV - August 17, 2017
Switching to raltegravir from efavirenz is associated with significant improvements in liver steatosis for HIV-positive people with non-alcoholic fatty liver disease, Spanish investigators report in the online edition of Clinical Infectious Diseases. The benefits of changing therapy were observed in people with and without active hepatitis C virus (HCV) co-infection.
Peripheral artery disease more common in people with HIV with lower CD4 counts - August 15, 2017
Peripheral artery disease, one of the most common forms of cardiovascular disease, occurs more frequently in people with HIV who have CD4 cell counts below 500, regardless of whether they smoke or have other risk factors for cardiovascular disease, an analysis of the large US Veterans Aging Cohort Study has

CEU Continuing Education for
Social Work CEUs, Psychology CEUs, Counselor CEUs, MFT CEUs

 


OnlineCEUcredit.com Login


Forget your Password Reset it!